| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |